Inhaled Beta Agonist Bronchodilator Does Not Affect Trans-diaphragmatic Pressure Gradient but Decreases Lower Esophageal Sphincter Retention Pressure in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Gastroesophageal Reflux Disease (
about
Inhaled Beta Agonist Bronchodilator Does Not Affect Trans-diaphragmatic Pressure Gradient but Decreases Lower Esophageal Sphincter Retention Pressure in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Gastroesophageal Reflux Disease (
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Inhaled Beta Agonist Bronchodi ...... troesophageal Reflux Disease (
@en
Inhaled Beta Agonist Bronchodi ...... Obstructive Pulmonary Disease
@nl
type
label
Inhaled Beta Agonist Bronchodi ...... troesophageal Reflux Disease (
@en
Inhaled Beta Agonist Bronchodi ...... Obstructive Pulmonary Disease
@nl
prefLabel
Inhaled Beta Agonist Bronchodi ...... troesophageal Reflux Disease (
@en
Inhaled Beta Agonist Bronchodi ...... Obstructive Pulmonary Disease
@nl
P2093
P2860
P1476
Inhaled Beta Agonist Bronchodi ...... ophageal Reflux Disease (GERD)
@en
P2093
Amilcar M Bigatao
Jose R Jardim
Leonardo M Del Grande
Marco G Patti
P2860
P2888
P304
P356
10.1007/S11605-016-3192-1
P577
2016-06-27T00:00:00Z